Clinical Trial Update: The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry

View source ↗

Summary

This multi-center case registry assesses the use of recombinant activated factor VII (rFVIIa) in trauma patients with traumatic hemorrhage and hemorrhagic shock…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock
• Traumatic Hemorrhage

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: University of California, San Francisco | Conditions: Traumatic Hemorrhage, Hemorrhagic Shock | Status: COMPLETED